KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Cash from Financing Activities: 2017-2025

Historic Cash from Financing Activities for Twist Bioscience (TWST) over the last 9 years, with Sep 2025 value amounting to $28.5 million.

  • Twist Bioscience's Cash from Financing Activities rose 53.68% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.5 million, marking a year-over-year increase of 314.22%. This contributed to the annual value of $28.5 million for FY2025, which is 314.22% up from last year.
  • According to the latest figures from FY2025, Twist Bioscience's Cash from Financing Activities is $28.5 million, which was up 314.22% from $6.9 million recorded in FY2024.
  • Twist Bioscience's Cash from Financing Activities' 5-year high stood at $329.2 million during FY2021, with a 5-year trough of $911,000 in FY2023.
  • For the 3-year period, Twist Bioscience's Cash from Financing Activities averaged around $12.1 million, with its median value being $6.9 million (2024).
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first tumbled by 99.66% in 2023, then surged by 656.31% in 2024.
  • Twist Bioscience's Cash from Financing Activities (Yearly) stood at $329.2 million in 2021, then fell by 17.82% to $270.5 million in 2022, then crashed by 99.66% to $911,000 in 2023, then spiked by 656.31% to $6.9 million in 2024, then soared by 314.22% to $28.5 million in 2025.